Citation Impact
Citing Papers
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Risk Factors for Venous Thromboembolism
2003 Standout
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014
2015 Standout
From stress to inflammation and major depressive disorder: A social signal transduction theory of depression.
2014 Standout
Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials
2003 Standout
Relationship between heparin anticoagulation and clinical outcomes in coronary stent intervention
2003
Revisiting the culprit lesion in non–Q-wave myocardial infarction
2002
A Clinical Trial of Vena Caval Filters in the Prevention of Pulmonary Embolism in Patients with Proximal Deep-Vein Thrombosis
1998 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
The β-Thalassemias
1999 Standout
Effect of Hydroxyurea on the Frequency of Painful Crises in Sickle Cell Anemia
1995 Standout
Systematic Direct Angioplasty and Stent-Supported Direct Angioplasty Therapy for Cardiogenic Shock Complicating Acute Myocardial Infarction: In-Hospital and Long-Term Survival
1998
Prevention of Venous Thromboembolism in General Surgical Patients
1988
Heparin-Induced Thrombocytopenia
1998
Fetal Hemoglobin in Sickle Cell Anemia: Determinants of Response to Hydroxyurea
1997
Subcutaneous Low-Molecular-Weight Heparin Compared with Continuous Intravenous Heparin in the Treatment of Proximal-Vein Thrombosis
1992 Standout
The molecular basis of blood coagulation
1988 Standout
Reduction in Fatal Pulmonary Embolism and Venous Thrombosis by Perioperative Administration of Subcutaneous Heparin
1988
Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome
2005 Standout
Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura
2001 StandoutNature
Endoplasmic reticulum stress: cell life and death decisions
2005 Standout
Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
2009 Standout
Antithrombotic Therapy for VTE Disease
2012 Standout
Thrombolytic therapy for pulmonary embolism
2009
The Clinical Course of Pulmonary Embolism
1992 Standout
11 The molecular genetics of familial venous thrombosis
1994
Antithrombotic Therapy for Venous Thromboembolic Disease
1989
Prevention of Venous Thromboembolism
2004 Standout
Effect of hydroxyurea on the rheological properties of sickle erythrocytes in vivo
1989
Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer
2003 Standout
The additive value of tirofiban administered with the high-dose bolus in the prevention of ischemic complications during high-risk coronary angioplasty
2004
Sickle-cell disease
2010 Standout
Hemodynamic effects of inhaled nitric oxide in right ventricular myocardial infarction and cardiogenic shock
2004
Evidence for Prevention of Death and Myocardial Infarction With Platelet Membrane Glycoprotein IIb/IIIa Receptor Blockade by Abciximab (c7E3 Fab) Among Patients With Unstable Angina Undergoing Percutaneous Coronary Revascularization fn1fn1This study was supported by Centocor, Inc., Malvern, Pennsylvania.
1997
Homology requirements for unequal crossing over in humans.
1991 StandoutNobel
Antithrombotic Therapy in Patients Undergoing Percutaneous Coronary Intervention
2001
Abciximab and bleeding during coronary surgery: results from the EPILOG and EPISTENT trials
2000
World distribution of factor V Leiden
1995 Standout
Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study
2001 Standout
Antithrombotic Therapy for Venous Thromboembolic Disease
2001 Standout
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
2006 Standout
Treatment of Sickle Cell Anemia with Hydroxyurea and Erythropoietin
1990
Cardiopulmonary cerebral resuscitation using emergency cardiopulmonary bypass, coronary reperfusion therapy and mild hypothermia in patients with cardiac arrest outside the hospital
2000
A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients
1999 Standout
Pharmacotherapeutic Aspects of Unfractionated and Low Molecular Weight Heparins
1990
Treatment of Comatose Survivors of Out-of-Hospital Cardiac Arrest with Induced Hypothermia
2002 Standout
Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders
2011 Standout
Antibodies to von Willebrand Factor–Cleaving Protease in Acute Thrombotic Thrombocytopenic Purpura
1998 Standout
Heparin-associated Thrombocytopenia: A Critical Review and Pooled Analysis
1993
Extended Therapy with Intravenous Arginine Butyrate in Patients with β-Hemoglobinopathies
1995
Reperfusion therapy in elderly patients with acute myocardial infarction
2002
Impact of the patient population on the risk for heparin-induced thrombocytopenia
2000 Standout
Hydroxyurea induction of hemoglobin F production in sickle cell disease: relationship between cytotoxicity and F cell production
1986
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Inhibition of Platelet Glycoprotein IIb/IIIa with Eptifibatide in Patients with Acute Coronary Syndromes
1998 Standout
The intracellular distribution and pattern of expression of Mcl-1 overlap with, but are not identical to, those of Bcl-2.
1995
Mild Therapeutic Hypothermia to Improve the Neurologic Outcome after Cardiac Arrest
2002 Standout
Prostanoid Receptors: Structures, Properties, and Functions
1999 Standout
Coordinate accumulation of the mRNAs for the alpha, beta, and gamma chains of rat fibrinogen following defibrination.
1982
A phase I study of pivaloyloxymethyl butyrate, a prodrug of the differentiating agent butyric acid, in patients with advanced solid malignancies.
2002
Hydroxyurea: effects on hemoglobin F production in patients with sickle cell anemia [see comments]
1992
A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis
1996 Standout
Part 9: Post–Cardiac Arrest Care
2010 Standout
Induction of fetal hemoglobin production in subjects with sickle cell anemia by oral sodium phenylbutyrate
1994
Oral sodium phenylbutyrate therapy in homozygous beta thalassemia: a clinical trial
1995
Insect immunity: developmental and inducible activity of the Drosophila diptericin promoter.
1992 StandoutNobel
Treatment of sickle cell anemia with 5-azacytidine results in increased fetal hemoglobin production and is associated with nonrandom hypomethylation of DNA around the gamma-delta-beta-globin gene complex.
1983
Individual Variation in the Production and Survival of F Cells in Sickle-Cell Disease
1978
The cellular basis for different fetal hemoglobin levels among sickle cell individuals with two, three, and four alpha-globin genes
1987
Genetic Dissection of Complex Traits
1994 StandoutScience
Hydroxyurea enhances fetal hemoglobin production in sickle cell anemia.
1984
Right Ventricular Function in Cardiovascular Disease, Part I
2008 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
CpG-rich islands and the function of DNA methylation
1986 StandoutNature
Low-Molecular-Weight Heparins
1997 Standout
Familial Dysfibrinogenemia and Thrombophilia
1995
Development and validation of a predictive model for chemotherapy-associated thrombosis
2008 Standout
Cellular and Molecular Regulation of Muscle Regeneration
2004 Standout
THE PHENOMENON OF THE ACUTE PHASE RESPONSE*
1982 Standout
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Chemical Chaperones Reduce ER Stress and Restore Glucose Homeostasis in a Mouse Model of Type 2 Diabetes
2006 StandoutScience
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Argatroban Anticoagulant Therapy in Patients With Heparin-Induced Thrombocytopenia
2001 Standout
An analysis of fetal hemoglobin variation in sickle cell disease: the relative contributions of the X-linked factor, beta-globin haplotypes, alpha-globin gene number, gender, and age
1995
Fibrin deposition accelerates neurovascular damage and neuroinflammation in mouse models of Alzheimer's disease
2007
Fetal hemoglobin levels in sickle cell disease and normal individuals are partially controlled by an X-linked gene located at Xp22.2
1992
Factors affecting prepubertal growth in homozygous sickle cell disease.
1996
Antithrombotic Therapy for Venous Thromboembolic Disease
1995
Recombination and balanced chromosome polymorphism suggested by DNA sequences 5' to the human delta-globin gene.
1983 StandoutNobel
Plasmin activity is required for myogenesis in vitro and skeletal muscle regeneration in vivo
2002
Works of Bell Wr being referenced
The effects of ancrod, the coagulating enzyme from the venom of Malayan pit viper (A. rhodostoma) on prothrombin and fibrinogen metabolism and fibrinopeptide A release in man.
1978
Microscopic method for assaying F cell production: illustrative changes during infancy and in aplastic anemia
1978
Thrombolysis in myocardial Infarction (TIMI) trial–phase I
1990
Stimulation of fibrinogen synthesis: a possible functional role of fibrinogen degradation products
1980
Fibrinogen Baltimore I: polymerization defect associated with a gamma 292Gly----Val (GGC----GTC) mutation
1990
Regulation of fibrinogen biosynthesis: effect of fibrin degradation products, low-molecular-weight peptides of fibrinogenolysis, and fibrinopeptides A and B.
1979
Changes in the plasma fibrinolytic system during urokinase therapy: comparison of tissue culture urokinase with urinary source urokinase in patients with pulmonary embolism.
1978
Low-dose heparin--concern and perspectives.
1979
Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome relapse: frequency, pathogenesis, and meaning.
1997
Polymerization defect of fibrinogen Baltimore III due to a gamma Asn308- ---Ile mutation
1990
Heparin-associated thrombocytopenia and thrombosis.
1988
Microscopic method for assaying F cell production: illustrative changes during infancy and in aplastic anemia
1978